Presentació dels Hospitals
Col·labora

PRE-CLINICAL THERAPEUTICS PIPELINE PROGRAM

MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH

Objecte

Topic: Parkinson.

Destination:

Call for grants for pre-clinical research projects to encourage and accelerate the development of anti-Parkinson’s therapies with the potential to fundamentally alter the course of the disease or significantly improve symptom management . To meet this goal, we currently only accept applications from industry groups and academia-industry associations. Specifically, this annuity establishes the following funding priority:

Identify, validate or develop novel pharmacological and non-pharmacological therapies through any of the pre-clinical stages of the therapeutics discovery and development process.

Test repurposed/repositioned therapies hitting priority PD pathways/targets in preclinical PD models

Budget: $250,000-$2,000,000.

Duration: 2 years.

Are you interested in this call?

Estàs interessat?

Omple el següent formulari per rebre més informació: